Barekat Pharmaceutical Group (BAREKAT) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- BAREKAT
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 |
|---|---|---|---|---|---|
| درآمد سود تضمین شده | 32 | 3,793 | 7,788 | 383 | 12,167 |
| Other income | 799,817 | 0 | 0 | 0 | 0 |
| Total operating revenue | 799,849 | 318,285 | 7,788 | 1,378 | 29,196 |
| هزینه های حقوق، دستمزد و مزایا | -485,936 | -283,819 | -242,892 | -223,217 | -139,922 |
| Depreciation expense | -9,825 | -9,676 | -6,531 | - | - |
| Other expenses | -116,434 | -89,141 | -52,945 | 0 | 0 |
| جمع هزینه های عملیاتی | -612,195 | -390,886 | -308,968 | -223,217 | -139,922 |
| Operating profit (loss) | 187,654 | -72,601 | -301,180 | -221,839 | -110,726 |
| Finance costs | -224,349 | -215,265 | -276,232 | -231,605 | -94,143 |
| Other non-operating income and expenses | 8,319 | 15,941 | 0 | -3,415 | 385,951 |
| Profit (loss) from continuing operations before tax | -28,376 | -271,925 | -577,412 | -456,859 | 181,082 |
| Net profit (loss) from continuing operations | -28,376 | -271,925 | -577,412 | -456,859 | 181,082 |
| Net profit (loss) | -28,376 | -271,925 | -577,412 | -456,859 | 181,082 |
| Operating (rials) | 11 | -4 | -18 | -30 | -15 |
| Non-operating (rials) | -13 | -12 | -16 | -32 | 40 |
| Arising from continuing operations | -2 | -16 | -34 | - | - |
| سود (زیان) پایه هر سهم (ریال) | -2 rials | -16 rials | -34 rials | -62 rials | 25 rials |
| سود (زیان) خالص هر سهم (ریال) | -1 rials | -15 rials | -33 rials | -62 rials | 25 rials |
| Capital | 17,340,000 | 17,340,000 | 17,340,000 | 7,340,000 | 7,340,000 |
Reporting periods
32 periods are on file for this report, from the period ending 1395/12/30 to the period ending 1405/06/31.